Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Eribulin
Sponsor: Istituti Ospitalieri di Cremona